Trials find cheap alternative to sight loss treatment as effective as licensed drug
The Macular Disease Society welcomes the findings of two important trials comparing Lucentis and Avastin for wet AMD.
Sight Loss and Vision Survey
Are you affected by sight loss or an eye condition, a carer for someone who has, or an eye health professional? If yes, why not take this survey and help change the future of eye research.
Judicial review of Avastin use
Pharmaceutical company Novartis has permission for a judicial review on the NHS use of Avastin to treat wet age-related macular degeneration.
25th anniversary awards launched
Volunteers, fundraisers, eye care professionals and support workers are all set to be honoured by the Macular Disease Society 25th Anniversary Awards for Excellence.
AOP awards launched
The 2012 Association of Optometrists (AOP) awards have launched – vote for your winners out of 16 different categories, including Charity of the Year. Deadline is 31 May
Volunteer speakers
If you enjoy helping others understand more about sight loss, why not become a Volunteer Speaker? Two training days are coming up: Chester, 23 May and Lincoln, 13 June.
